Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 25 | 0 | 5 | 0 | 134,30 € | 137,96 € | 2,72 % |
| Icon plc | 18 | 0 | 6 | 0 | 279,10 € | 318,99 € | 14,29 % |
| United Therapeutics | 17 | 0 | 2 | 0 | 236,20 € | 289,92 € | 22,74 % |
| Exelixis Inc. | 17 | 0 | 2 | 0 | 20,26 € | 25,64 € | 26,53 % |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | 12,06 € | 22,78 € | 88,85 % |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | 40,60 € | 82,93 € | 104,26 % |
| Halozyme Therapeutics Inc. | 13 | 0 | 2 | 0 | 36,78 € | 53,50 € | 45,45 % |
| Repligen Corp. | 12 | 0 | 0 | 0 | 148,70 € | 182,96 € | 23,04 % |
| Alkermes plc | 12 | 2 | 1 | 0 | 22,80 € | 34,08 € | 49,48 % |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | 216,50 € | 247,61 € | 14,37 % |
| QIAGEN NV | 9 | 0 | 0 | 0 | 40,47 € | 47,44 € | 17,22 % |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | 372,10 € | 421,61 € | 13,30 % |
| Xencor Inc. | 9 | 1 | 1 | 0 | 18,70 € | 31,74 € | 69,73 % |
| PTC Therapeutics Inc. | 13 | 6 | 2 | 1 | 29,80 € | 41,51 € | 39,30 % |
| Taro Pharmaceutical Industries Ltd | 7 | 0 | 1 | 0 | 39,40 € | - | - |
| MorphoSys AG | 7 | 0 | 0 | 0 | 65,90 € | 65,00 € | -1,37 % |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | 110,40 € | - | - |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | 30,60 € | 38,99 € | 27,41 % |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | 18,20 € | 45,10 € | 147,77 % |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | 0,47 € | 1,75 € | 273,13 % |
| Dr. Reddy's Laboratories Ltd. ADR | 5 | 1 | 1 | 0 | 68,00 € | 73,92 € | 8,71 % |
| Perrigo Co. plc | 3 | 0 | 1 | 0 | 30,77 € | 35,99 € | 16,95 % |
| Bausch Health Companies Inc. | 3 | 0 | 1 | 0 | 8,42 € | 16,47 € | 95,61 % |
| Catalent Inc. | 2 | 0 | 0 | 0 | 52,32 € | 55,00 € | 5,12 % |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | 1,49 € | 3,70 € | 147,66 % |